Vertex Pharmaceuticals (VRTX) EBITDA Margin Growth (1y) (2010 - 2026)
Vertex Pharmaceuticals (VRTX) EBITDA Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | - |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | 3,609.00 |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | 1,536.00 |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.55 Bn | 54.80 Bn | 3.31 Bn | -957.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,536.00 |
| Dec 31, 2025 | 257.00 |
| Sep 30, 2025 | -171.00 |
| Jun 30, 2025 | 17,168.00 |
| Mar 31, 2025 | -1,961.00 |
| Dec 31, 2024 | -403.00 |
| Sep 30, 2024 | -153.00 |
| Jun 30, 2024 | -17,402.00 |
| Mar 31, 2024 | 955.00 |
| Dec 31, 2023 | -562.00 |
| Sep 30, 2023 | -647.00 |
| Jun 30, 2023 | -921.00 |
| Mar 31, 2023 | -1,682.00 |
| Dec 31, 2022 | 253.00 |
| Sep 30, 2022 | -488.00 |
| Jun 30, 2022 | 5,249.00 |
| Mar 31, 2022 | -186.00 |
| Dec 31, 2021 | -347.00 |
| Sep 30, 2021 | 945.00 |
| Jun 30, 2021 | -4,921.00 |